paraphrase: Thanks thanks ludwig.
sees q3 revenue rose 8 percent to $859 million.
q3 sales rose slower than previous quarter on a year-over-year basis and slower than guidance previously communicated.
compname reports q2 adjusted ebitda per share $0.06.
q2 adjusted earnings per share $0.18.
previously anticipated that impact to impact q3 2021 net income from operations from operations would be about $30 million.
q2 2020 guidance remains on track to meet strong demand conditions.
raises q3 guidance.
q3 non-gaap earnings per share $1.44 excluding items.
qtrly u.s. products net sales rose 7%.
q3 revenue increased 19%.
qtrly total revenue of $946 million, up 9 percent compared with previous quarter.
qtrly revenue rose 3% to $756 million.
compname reports q2 2020 results; full year results include strong comparable net sales of $4.2 billion versus refinitiv ibes estimate of $3.8 billion.
in united states healthcare system - during q3, we believe soliris volumes were significantly higher than we expected.
q3 volume growth was about 13% across all periods.
